High risk prescribing in older Australians: prevalence, outcomes and potential for intervention
澳大利亚老年人的高风险处方:患病率、结果和干预潜力
基本信息
- 批准号:nhmrc : 1024450
- 负责人:
- 金额:$ 39.72万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:Project Grants
- 财政年份:2012
- 资助国家:澳大利亚
- 起止时间:2012-01-01 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Older people are the most likely to be prescribed medicines yet they are the most likely to be harmed by their medicines. The extent of and trends in high risk prescribing among older Australians are not known. This project will use large-scale linked data to determine the prevalence, risk factors, clinical consequences and costs of high risk prescribing among older people in Australia. The findings of this project will be used to identify targets for minimising harm relating to use of medicines.
老年人最有可能被开出处方药,但他们也最有可能受到他们的药物的伤害。老年澳大利亚人开高风险处方的程度和趋势尚不清楚。该项目将使用大规模关联数据来确定澳大利亚老年人中高风险处方的流行率、风险因素、临床后果和成本。该项目的结果将被用来确定将与使用药物有关的危害降至最低的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dr Danijela Gnjidic其他文献
Dr Danijela Gnjidic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dr Danijela Gnjidic', 18)}}的其他基金
Optimising pharmaceutical care for people with dementia in acute care settings
优化急性护理环境中痴呆症患者的药学护理
- 批准号:
nhmrc : 1136849 - 财政年份:2017
- 资助金额:
$ 39.72万 - 项目类别:
Targeted Calls
Optimising pharmaceutical care for people with dementia in acute care settings
优化急性护理环境中痴呆症患者的药学护理
- 批准号:
nhmrc : GNT1136849 - 财政年份:2017
- 资助金额:
$ 39.72万 - 项目类别:
Boosting Dementia Research Initiative
How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in Australia, Canada the European Union and the United States
如何最好地保护公众健康:澳大利亚、加拿大、欧盟和美国药品监管安全警告的比较分析
- 批准号:
nhmrc : 1122332 - 财政年份:2017
- 资助金额:
$ 39.72万 - 项目类别:
Project Grants
Clinical outcomes from high risk medicines in older Australians
澳大利亚老年人高风险药物的临床结果
- 批准号:
nhmrc : 1037571 - 财政年份:2012
- 资助金额:
$ 39.72万 - 项目类别:
Early Career Fellowships
相似海外基金
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Prescribing in High-Risk Older Patients with Type 2 Diabetes
基于连续血糖监测的干预措施为高危老年 2 型糖尿病患者安全处方胰岛素的实用临床试验
- 批准号:
10559099 - 财政年份:2023
- 资助金额:
$ 39.72万 - 项目类别:
Racial Disparities in Analgesic Prescribing for Post-Surgical Pain Management among Older Americans following Hip and Knee Replacement Surgeries
美国老年人髋关节和膝关节置换手术后术后疼痛管理镇痛处方的种族差异
- 批准号:
10508187 - 财政年份:2022
- 资助金额:
$ 39.72万 - 项目类别:
Optimizing prescribing decisions for hospitalized older adults with chronic conditions
优化患有慢性病的住院老年人的处方决策
- 批准号:
10672459 - 财政年份:2022
- 资助金额:
$ 39.72万 - 项目类别:
Understanding and Addressing Opioid and Benzodiazepine Co-prescribing among Older Adults with Cancer
了解和解决老年癌症患者中阿片类药物和苯二氮卓类药物的联合处方问题
- 批准号:
10560530 - 财政年份:2022
- 资助金额:
$ 39.72万 - 项目类别:
Specialty Provider Prescribing of Medications to Treat Opioid Use Disorder in Older Adults
专业医疗服务提供者开出治疗老年人阿片类药物使用障碍的药物
- 批准号:
10543834 - 财政年份:2022
- 资助金额:
$ 39.72万 - 项目类别:
Racial Disparities in Analgesic Prescribing for Post-Surgical Pain Management among Older Americans following Hip and Knee Replacement Surgeries
美国老年人髋关节和膝关节置换手术后术后疼痛管理镇痛处方的种族差异
- 批准号:
10693957 - 财政年份:2022
- 资助金额:
$ 39.72万 - 项目类别:
Optimizing prescribing decisions for hospitalized older adults with chronic conditions
优化患有慢性病的住院老年人的处方决策
- 批准号:
10506881 - 财政年份:2022
- 资助金额:
$ 39.72万 - 项目类别:
Understanding and Addressing Opioid and Benzodiazepine Co-prescribing among Older Adults with Cancer
了解和解决老年癌症患者中阿片类药物和苯二氮卓类药物的联合处方问题
- 批准号:
10371456 - 财政年份:2022
- 资助金额:
$ 39.72万 - 项目类别:
Specialty Provider Prescribing of Medications to Treat Opioid Use Disorder in Older Adults
专业医疗服务提供者开出治疗老年人阿片类药物使用障碍的药物
- 批准号:
10370787 - 财政年份:2022
- 资助金额:
$ 39.72万 - 项目类别:
Incidence and risk factors of inappropriate antibiotic prescribing and related adverse health outcomes among Ontario long-term care residents and marginalized older community-dwelling adults with COVID-19 (I-CARE)
安大略省长期护理居民和边缘化老年社区居民感染 COVID-19 时抗生素处方不当及相关不良健康结果的发生率和风险因素 (I-CARE)
- 批准号:
459264 - 财政年份:2021
- 资助金额:
$ 39.72万 - 项目类别:
Operating Grants